Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer
Breast cancer is the second leading cause of cancer death in women with increasing incidence. Hence, finding a diagnostic factor and/or potential drug target could lead to an earlier diagnosis or a more effective therapeutic protocol. It is shown that substance P (SP) through its receptor neurokinin-1 (NK1R) could initiate tumor cell proliferation, angiogenesis, and migration. This was a case–control study on 41 women with breast cancer and 34 healthy controls. Serum level of SP was measured using an ELISA method, and immunohistochemistry staining was performed to study NK1R expression in different cell compartments. Assessing serum SP values of patients showed significantly higher levels than those of healthy individuals. However, no significant correlation was found between SP levels and tumor criteria, but between SP and HER-2. Moreover, the percentage, intensity of staining as well as tissue distribution of NK1R were significantly higher in tumor tissues as compared with controls. Increased serum SP levels and NK1R tissue distribution were observed in patients with breast cancer as compared with their controls, highlighting the involvement of SP/NK1R complex in breast cancer incidence. NK1R profound expression in tumor cell cytoplasm and its significant correlation with the majority of cancer features can be of importance to be taken into consideration as a possible potential therapeutic target in future targeted therapeutic strategies. Furthermore, cytoplasmic expression of NK1R can be suggested as a potent prognostic factor as it has shown significant correlation with TNM and tumor grade.
KeywordsBreast cancer Substance P NK-1 receptor Cancer stage
We are very grateful to all patients who participated in this study. This work was based on the Research Project No. 922072, as the Master dissertation of Monireh Davoodian, financed by the Research Council of Mashhad University of Medical Sciences.
Compliance with ethical standards
Conflict of interest
Authors declare that they do not have any conflict of interest.
- 2.Chang MM, Leeman SE (1970) Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J Biol Chem 245(18):4784–4790Google Scholar
- 7.Mangano A, Abbate GM, Levrini L (2015) Substance P and pain in orthodontics: a brief review. Inflamm Cell Signal 2(4):e1027Google Scholar
- 11.Chen X-Y, Ru G-Q, Ma Y-Y, Xie J, Chen W-Y, Wang H-J, Wang S-B, Li L, Jin K-T, He X-L (2016) High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis. OncoTargets Ther 9:3595Google Scholar
- 18.Covenas R, Munoz M (2014) Cancer progression and substance P. Histol Histopathol 29(7):881–890Google Scholar
- 19.DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA: A Cancer J Clin 67(6):439–448Google Scholar
- 24.Espina C, McKenzie F, dos-Santos-Silva I (2017) Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Ann EpidemiolGoogle Scholar
- 27.Garcia-Recio S, Fuster G, Fernandez-Nogueira P, Pastor-Arroyo EM, Park SY, Mayordomo C, Ametller E, Mancino M, Gonzalez-Farre X, Russnes H (2013) Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-12-4573 Google Scholar
- 29.Ni T, Liu Y, Peng Y, Li M, Fang Y, Yao M (2016) Substance P induces inflammatory responses involving NF-κB in genetically diabetic mice skin fibroblasts co-cultured with macrophages. Am J Transl Res 8(5):2179Google Scholar
- 41.Brener S, González-Moles MA, Tostes D, Esteban F, Gil-Montoya JA, Ruiz-Avila I, Bravo M, Munoz M (2009) A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. Anticancer Res 29(6):2323–2329Google Scholar
- 42.Rosso M, Robles-Frías MJ, Coveñas R, Salinas-Martín MV, Muñoz M (2008) The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines. Tumor Biol 29(4):245–254CrossRefGoogle Scholar